Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Vox Sanguinis|November 21, 2007
A biochemical quality study of a pharmaceutically licenced coagulation active plasma (Octaplas) thawed by the SAHARA-III dry tempering system compared to the regular use of a water bathA Heger, J Römisch, T-E SvaeVox Sanguinis|March 14, 2007
Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in developmentA Heger, C Kannicht, J Römisch, et al.Vox Sanguinis|November 11, 2011
Removal of prion infectivity by affinity ligand chromatography during OctaplasLG® manufacturing--results from animal bioassay studiesA Heger, A Bailey, A Neisser-Svae, et al.Vox Sanguinis|April 28, 2009
Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process timeA Heger, T-E Svae, A Neisser-Svae, et al.Vox Sanguinis|June 25, 2009
Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLGA Neisser-Svae, A Bailey, L Gregori, et al.Biologicals : Journal of the International Association of Biological Standardization|February 28, 2006
Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate)M Stadler, G Gruber, C Kannicht, et al.Pageof 1